References:
1. Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, et al. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr 2017;181:S4-S15.e1.
2. Farrell MH, La Pean Kirschner A, Tluczek A, Farrell PM. Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status. J Pediatr 2020;224:37-43.e2.
3. Farrell MH, Sims AM, La Pean Kirschner A, Farrell PM, Tarini BA. Vulnerable Child Syndrome and Newborn Screening Carrier Results for Cystic Fibrosis or Sickle Cell. J Pediatr 2020;224:44-50.e1.
4. Çolak Y, Nordestgaard BG, Afzal S. Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population. Eur Respir J 2020;56(3):1–12.
5. Miller AC, Comellas AP, Hornick DB, Stoltz DA, Cavanaugh JE, Gerke AK, Welsh MJ, Zabner J, Polgreen PM. Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions. Proc Natl Acad Sci U S A 2020;117(3):1621–1627.
6. Martin C, Burgel PR. Carriers of a single CFTR mutation are asymptomatic: An evolving dogma? Eur Respir J 2020;56(3):10–13.
7. Schlüter DK, Southern KW, Dryden C, Diggle P, Taylor-Robinson D. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: A UK CF registry-based study. Thorax 2019:123–131.
8. Ďurč P, Foret F, Homola L, Malá M, Pokojová E, Vinohradská H, Dastych M, Krausová D, Nagy D, Bede O, et al. Skin wipe test: A simple, inexpensive, and fast approach in the diagnosis of cystic fibrosis. Pediatr Pulmonol 2020;55(7):1653–1660.
9. McColley SA, Elbert A, Wu R, Ren CL, Sontag MK, LeGrys VA. Quantity not sufficient rates and delays in sweat testing in US infants with cystic fibrosis. Pediatr Pulmonol 2020;55(11):3053–3056.
10. Munck A, Bourmaud A, Bellon G, Picq P, Farrell PM. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening. Pediatr Pulmonol 2020;55(4):918–928.
11. Rock MJ. How to define CRMS/CFSPID conversion to CF. Pediatr Pulmonol 2020;55(7):1548–1549.
12. Terlizzi V, Mergni G, Centrone C, Festini F, Taccetti G. Trend of sweat chloride values in a cohort of patients carrying CFTR mutations of varying clinical consequence: Is there a risk of increasing sweat chloride over time? Pediatr Pulmonol 2020;55(5):1089–1093.
13. Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B, Hempstead SE, Marshall B, Sabadosa KA, Elborn S, Boyle M, et al. International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax 2016;71(1):26–34.
14. Liu FF, Lew A, Andes E, McNamara S, Cassidy J, Whitmore S, Plunkett R, Ong T. Implementation strategies for depression and anxiety screening in a pediatric cystic fibrosis center: A quality improvement project. Pediatr Pulmonol 2020;55(12):3328–3336.
15. Quittner AL, Abbott J, Hussain S, Ong T, Uluer A, Hempstead S, Lomas P, Smith B. Integration of mental health screening and treatment into cystic fibrosis clinics: Evaluation of initial implementation in 84 programs across the United States. Pediatr Pulmonol 2020;55(11):2995–3004.
16. Borschuk AP, Molitor S, Everhart RS, Siracusa C, Filigno SS. Executive functioning in pediatric cystic fibrosis: A preliminary study and conceptual model. Pediatr Pulmonol 2020;55(4):939–947.
17. Lowery EM, Afshar M, West N, Kovacs EJ, Smith B, Joyce C. Self-reported alcohol use in the cystic fibrosis community. J Cyst Fibros 2020;19(1):84–90.
18. Toprak D, Nay L, McNamara S, Rosenberg AR, Rosenfeld M, Yi-Frazier JP. Resilience in adolescents and young adults with cystic fibrosis: A pilot feasibility study of the promoting resilience in stress management intervention. Pediatr Pulmonol 2020;55(3):638–645.
19. Amerio A, Sibilla F, Pescini R, Ciprandi R, Casciaro R, Grimaldi Filioli P, Porcelli C, Odone A, Costanza A, Aguglia A, et al. Mental health and cystic fibrosis: Time to move from secondary prevention to predictive medicine. Pediatr Pulmonol 2020;55(9):2204–2206.
20. Hente E, Sears R, Cotton S, Pallerla H, Siracusa C, Filigno SS, Boat T. A Pilot Study of Mindfulness-Based Cognitive Therapy to Improve Well-Being for Health Professionals Providing Chronic Disease Care. J Pediatr 2020;224:87-93.e1.
21. Olesen H V., Drevinek P, Gulmans VA, Hatziagorou E, Jung A, Mei-Zahav M, Stojnic N, Thomas M, Zolin A. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al. J Cyst Fibros 2020;19(2):321–327.
22. Prentice BJ, Ooi CY, Verge CF, Hameed S, Widger J. Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis. J Cyst Fibros 2020;19(5):700–703.
23. Chan C. Cystic fibrosis related diabetes: Revisiting the OGTT and alternative screening tests. J Cyst Fibros 2020;19(5):671–672.
24. Kilberg MJ, Sheikh S, Stefanovski D, Kubrak C, De Leon DD, Hadjiliadis D, Rubenstein RC, Rickels MR, Kelly A. Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia. J Cyst Fibros 2020;19(2):310–315.
25. Armaghanian N, Hetherington J, Parameswaran V, Chua EL, Markovic TP, Brand-Miller J, Steinbeck K. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test. Pediatr Pulmonol 2020;55(12):3391–3399.
26. Sherwood JS, Jafri RZ, Balliro CA, Zheng H, El-Khatib FH, Damiano ER, Russell SJ, Putman MS. Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study. J Cyst Fibros 2020;19(1):159–161.
27. Gur M, Bar-Yoseph R, Diab G, Hanna M, Rozen G, Daud F, Keidar Z, Toukan Y, Masarweh K, Nir V, et al. Understanding the interplay between factors that influence bone mineral density in CF. Pediatr Pulmonol 2020;55(10):2667–2673.
28. Trandel ET, Pilewski JM, Dellon EP, Jeong K, Yabes JG, Moreines LT, Arnold RM, Hoydich ZP, Kavalieratos D. Prevalence of unmet palliative care needs in adults with cystic fibrosis. J Cyst Fibros 2020;19(3):394–401.
29. Trandel ET, Kavalieratos D, Basile M, Hobler MR, Georgiopoulos AM, Chen E, Goggin JL, Goss CH, Hempstead SE, Faro A, et al. Palliative care skills in CF: Perspectives of adults with CF, caregivers, and CF care team members. Pediatr Pulmonol 2020;55(8):2017–2024.
30. Waldman E, Quinn M. Palliative care and cystic fibrosis: Opportunities for growth. Pediatr Pulmonol 2020;55(9):2179–2180.
31. Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med 2020;8(1):65–124.
32. Dogru D, Çakır E, Eyüboğlu TŞ, Pekcan S, Özçelik U. Cystic fibrosis in Turkey. Lancet Respir Med 2020;8(4):e17.
33. Shi R, Wang X, Lu X, Zhu Z, Xu Q, Wang H, Song L, Zhu C. A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis. Pediatr Pulmonol 2020;55(11):3005–3011.
34. Dogru D, Çakır E, Şişmanlar T, Çobanoğlu N, Pekcan S, Cinel G, Yalçın E, Kiper N, Şen V, S. Şen H, et al. Cystic fibrosis in Turkey: First data from the national registry. Pediatr Pulmonol 2020;55(2):541–548.
35. Shen Y, Tang X, Liu J, Li H, Zhao S. Pseudo-Bartter syndrome in Chinese children with cystic fibrosis: Clinical features and genotypic findings. Pediatr Pulmonol 2020;55(11):3021–3029.
36. Sismanlar Eyuboglu T, Dogru D, Çakır E, Cobanoglu N, Pekcan S, Cinel G, Yalçın E, Kiper N, Sen V, Selimoglu Sen H, et al. Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis. Pediatr Pulmonol 2020;55(8):2011–2016.
37. Owusu SK, Morrow BM, White D, Klugman S, Vanker A, Gray D, Zampoli M. Cystic fibrosis in black African children in South Africa: a case control study. J Cyst Fibros 2019;19:540–545.
38. Fitzgerald C, Linnane B, George S, Ni Chroinin M, Mullane D, Herzig M, Greally P, Elnazir B, Healy F, Mc Nally P, et al. Neonatal screening programme for CF: Results from the Irish Comparative Outcomes Study (ICOS). Pediatr Pulmonol 2020;55(9):2323–2329.
39. M S, A K, M D. First case of cystic fibrosis in Greenland – diagnosed by neonatal screening. J Cyst Fibros 2020;19(3):e14–e15.
40. Pasterkamp H, Menzies KJ, Bayomi DJ. Cystic fibrosis in Canadian Hutterites. Pediatr Pulmonol 2020;55(2):526–532.
41. Zybert K, Wozniacki L, Tomaszewska-Sobczyńska A, Wertheim-Tysarowska K, Czerska K, Ołtarzewski M, Sands D. Clinical characteristics of rare CFTR mutations causing cystic fibrosis in Polish population. Pediatr Pulmonol 2020;55(8):2097–2107.
42. Rowbotham NJ, Smith S, Leighton PA, Rayner OC, Gathercole K, Elliott ZC, Nash EF, Daniels T, Duff AJA, Collins S, et al. The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers. Thorax 2018;73(4):388–390.
43. Hollin I, Donaldson S, Roman C, Aliaj E, Riva D, Boyle M, Borowitz D. Beyond the expected: Identifying broad research priorities of researchers and the cystic fibrosis community. J Cyst Fibros 2019;18(3):375–377.
44. Davies G, Rowbotham NJ, Smith S, Elliot ZC, Gathercole K, Rayner O, Leighton PA, Herbert S, Duff AJ, Chandran S, et al. Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials. J Cyst Fibros 2020;19(3):499–502.
45. Cooley L, Hudson J, Potter E, Raymond KF, George C, Georgiopoulos AM. Clinical communication preferences in cystic fibrosis and strategies to optimize care. Pediatr Pulmonol 2020;55(4):948–958.
46. Haywood KB, Goralski JL. The specialist as primary care provider in CF. J Cyst Fibros 2020;19(5):844–845.
47. Douglas TA, Pooley JA, Shields L, Stick SM, Branch-Smith C. Early disease surveillance in young children with cystic fibrosis: A qualitative analysis of parent experiences. J Cyst Fibros 2020;(xxxx):5–9.
48. Oates GR, Harris WT, Gutierrez HH, Mims C, Rutland SB, Ott C, Niranjan SJ, Scarinci IC, Walley SC. Tobacco smoke exposure in pediatric cystic fibrosis: A qualitative study of clinician and caregiver perspectives on smoking cessation. Pediatr Pulmonol 2020;55(9):2330–2340.
49. Zobell JT, Moss J, Heuser SM, Asfour F. Impact of pharmacy technicians as part of an integrated health-system pharmacy team on improvement of medication access in the care of cystic fibrosis patients. Pediatr Pulmonol 2020;55(12):3351–3357.
50. Reynaud Q, Rousset Jablonski C, Poupon-Bourdy S, Denis A, Rabilloud M, Lemonnier L, Nove-Josserand R, Durupt S, Touzet S, Durieu I. Pregnancy outcome in women with cystic fibrosis and poor pulmonary function. J Cyst Fibros 2020;19(1):80–83.
51. Vijayasingam A, Frost E, Wilkins J, Gillen L, Premachandra P, McLaren K, Gilmartin D, Picinali L, Vidal-Diez A, Borsci S, et al. Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis. Thorax 2020;75(8):632–639.